From Volume to Value: Strategising launch readiness in 2020

Posted by Andre Moa on Feb 13, 2020 11:07:00 AM

 

One notable characteristic of the launch readiness landscape as we settle into 2020 is the lower volume of innovative drugs entering the marketplace. The record number of approvals granted in 2018 by the two most influential agencies, the US Food and Drug Administration and the European Medicines Agency, did not hold up in 2019.

Read More

Topics: Pharma launch planning, Pharma trends, Market access, launch readiness, Tender Management

5 Pharma Trends for 2020: Counting the value and cost of innovation

Posted by Andre Moa on Jan 16, 2020 12:48:01 PM

 

For all its reliance on innovation as a business driver, pharmaceuticals is a traditionally conservative industry that advances by small and careful steps. As we  map out some of the dominant pharma trends for 2020, perhaps we should also reflect on what ‘innovation’ actually means, what its value is, and what it costs.

Read More

Topics: Pharma launch planning, Pharma trends, Market access, launch readiness, Tender Management, #2019 Pharma Trends

2019 New Drug Approvals And Updates: The Year In Review

Posted by Andre Moa on Dec 6, 2019 12:24:26 PM

Launch excellence for pharmaceuticals depends on a multitude of factors, from pricing, reimbursement and health technology assessment (HTA) to positioning, sequencing, sales, marketing, media coverage and the competitive landscape. None of these can get off the ground, though, without regulatory approvals in key markets. Here, we tally up 2019 new drug approvals to date in the US and the European Union.

 

Read More

Topics: launch readiness

How digital transformation can streamline your new pharma product launch

Posted by Andre Moa on Nov 5, 2019 2:47:15 PM

Digital technology and media have disrupted and revolutionised pharmaceuticals from research to market entry and beyond. That presents some challenges to product launches but also opportunities to maximise launch efficiency. In an ever more global, complex and volatile market environment, digital transformation of a traditionally conservative industry creates fresh possibilities to bring both launch strategy and execution into alignment.  

Read More

Topics: launch readiness

How to stay on top of your global market access challenges

Posted by Avel Shah on Sep 17, 2019 9:15:00 AM

 

 

 

Your dazzling new pharmaceutical product is going nowhere fast unless it reaches patients on time and on terms that balance affordability with the need to recoup years of investment. Is your organisation really taking control of the market access challenges that make all the difference between launch success and an also-ran?

Read More

Topics: launch readiness